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Introduction: Monosodium urate (MSU) microcrystals present in bone tissues of chronic gout can be ingested by
nonprofessional phagocytes like osteoblasts (OBs) that express NLRP3 (nucleotide-binding domain and leucine-rich
repeat region containing family of receptor protein 3). MSU is known to activate NLRP3 inflammasomes in
professional phagocytes. We have identified a new role for NLRP3 coupled to autophagy in MSU-stimulated
human OBs.
Methods: Normal human OBs cultured in vitro were investigated for their capacity for phagocytosis of MSU
microcrystals by using confocal microscopy. Subsequent mineralization and matrix metalloproteinase activity were
evaluated, whereas regulatory events of phagocytosis were deciphered by using signaling inhibitors, phosphokinase
arrays, and small interfering RNAs. Statistics were carried out by using paired or unpaired t tests, and the one-way
ANOVA, followed by multiple comparison test.
Results: Most of the OBs internalized MSU in vacuoles. This process depends on signaling via PI3K, protein
kinase C (PKC), and spleen tyrosine kinase (Syk), but is independent of Src kinases. Simultaneously, MSU decreases
phosphorylation of the protein kinases TOR (target of rapamycin) and p70S6K. MSU activates the cleavage of
microtubule-associated protein light chain 3 (LC3)-I into LC3-II, and MSU microcrystals are coated with GFP-tagged
LC3. However, MSU-stimulated autophagy in OBs absolutely requires the phagocytosis process. We find that MSU
upregulates NLRP3, which positively controls the formation of MSU-autophagosomes in OBs. MSU does not increase
death and late apoptosis of OBs, but reduces their proliferation in parallel to decreasing their competence for
mineralization and to increasing their matrix metalloproteinase activity.
Conclusions: MSU microcrystals, found locally encrusted in the bone matrix of chronic gout, activate phagocytosis
and NLRP3-dependent autophagy in OBs, but remain intact in permanent autophagosomes while deregulating OB
functions.Introduction
Uric acid is an obligatory physiologic breakdown prod-
uct of purine metabolism. This compound is soluble in
the cytosol of cells and in plasma. However, uric acid in
the extracellular milieu and tissues rapidly crystallizes
because of its very low water solubility. Elevated blood
uric acid is associated with several pathologies, the most
representative being gout, but also hypertension, meta-
bolic syndrome, and renal disease [1,2]. Interestingly, uric
acid cannot always be considered deleterious because it* Correspondence: Patrice.Poubelle@crchul.ulaval.ca
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reproduction in any medium, provided the orhas been recognized as an antioxidant, at least in vitro, al-
though this effect seems uncertain in vivo [3-5]. Uric acid
and monosodium urate (MSU) microcrystals released by
injured and dying cells can be considered endogenous
danger signals because they have been shown to stimulate
maturation and functions of dendritic cells [6]. In
addition, extracellular MSU secondary to cell injury and
autoinflammatory diseases has been shown to stimulate
the NLRP3 (nucleotide-binding domain and leucine-rich
repeat region containing family of receptor protein 3)
inflammasome [7-9]. Interestingly, although the hetero-
cyclic chemical compound monosodium urate has no spe-
cific receptor, it can activate cells in different ways. MSU
microcrystals can interact opportunistically with different
receptors like CD14, CD16, and TLR-2/TLR-4, leading toLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[10-12]. The same crystals were also shown nonspecifi-
cally to bind to dendritic cell-surface lipids with activation
of immunoreceptor tyrosine-based motifs and subsequent
recruitment of spleen tyrosine kinase (Syk) and PI3K acti-
vation [13]. Moreover, these different pathways of cell acti-
vation by MSU are followed by phagocytosis of the solid
particles.
Phagocytosis, a process of endocytosis or internaliza-
tion of particles, is aimed at eliminating cell debris,
microorganisms, and foreign bodies in multicellular or-
ganisms. This primary major function is mainly devoted
to professional phagocytes like macrophages, neutro-
phils, and dendritic cells. However, other cell types, like
fibroblasts and osteoblasts, are competent in this respect
[14-16]. Osteoblasts (OBs) can be considered nonprofes-
sional phagocytes that are capable of internalizing differ-
ent types of particles, like titanium and other small
particles of biomaterials used in medical implants, latex,
and various microbial pathogens [15,17-21]. They are
also able to ingest MSU, leading to the production of
inflammatory mediators and modifications of their func-
tional phenotype [22]. Although specific signaling can
differ, depending on the types of receptors activated by
particles [23,24], the major pathways associated with
phagocytosis by the professional phagocytes include the
Src-family tyrosine kinases (Hck, Lyn, Fgr, Fyn, Lck),
Syk, and PI3K. Interestingly, MSU interaction with neu-
trophils was shown to be associated with a diversified
and distinct pattern of protein tyrosine phosphorylation
[25-27]. MSU was also shown to activate different sig-
naling pathways in mononuclear phagocytes like ERK-1/
ERK-2, p38 MAPK, NF-κB, and AP-1 [28]. However, sig-
naling pathways activated by MSU internalization in
OBs remain unknown. It is also relevant that the bone
matrix close to MSU deposits was shown to be irregu-
larly calcified, that MSU microcrystals were abundant in
new bone matrix, and that these events are associated
with a low density of OBs dispersed on the osteoid [29].
As a corollary, MSU crystals in the extracellular milieu
could lead to different sequences of cell activation, such
as initial nonspecific contact with cell membrane, and/or
opportunistic occupancy of various receptors with sub-
sequent activation of intracellular signals that lead to
their phagocytosis. It is important that phagocytosis has
been linked to another highly conserved process in-
volved in the destruction of foreign particles present in
the cytosol and named autophagy [30,31].
Eukaryotic cells, to maintain their homeostasis, have
lysosomes that are primary organelles with the capacity
for degrading waste products and cell debris. Unfavor-
able conditions of life require that these cells can adapt
their lysosomal responses of degradation. Autophagy
(process of self-eating) is one of these adaptive responsesby which cells can remove damaged or unwanted intra-
cellular substances [32]. Thus, this housekeeping func-
tion allows the turnover of long-lived proteins, of
cytoplasmic organelles, as well as of pathogens, and is
related to cellular functions during nutrient starvation,
cell death, repair, and infection [33]. Intracellular com-
ponents to be degraded through activation of macroau-
tophagy are first engulfed in double-membrane vesicles,
named autophagosomes, before being fused with the
lysosomal membrane and eventually cleared [34].
In humans, the microtubule-associated protein light
chain 3 (LC3) is generated as a precursor immediately
transformed into its cytosolic unconjugated form, LC3-I,
which is then conjugated to the membrane phospholipid
phosphatidylethanolamine to form LC3-II. This lipidated
membrane-bound LC3-II is localized to preautophago-
somes and autophagosomes. The amount of LC3-II cor-
relates with the number of autophagosomes and has an
apparent molecular mass smaller than that of LC3-I
[35]. Thus, the evaluation of LC3-I cleavage into LC3-II
reflects the activation of autophagy [36]. Although au-
tophagy is highly regulated, the serine/threonine protein
kinases TOR (target of rapamycin) appear key factors
that tightly repress autophagy in yeast and mammalian
cells. TOR negatively regulates the activity of Atg1, a
protein kinase fundamental for autophagy, and the re-
cruitment of LC3 [37,38]. In addition, the PI3Ks are
implicated in the suppression of autophagy by acting
upstream of TOR [39]. The majority of cell types
have this primary function of autophagy. Deregulated
autophagy has been associated with human diseases
and represents a potential target for new therapeutic
strategies [40].
Cell homeostasis is characterized by a low level of au-
tophagy. Stress conditions activate the diverse and com-
plex mechanisms of autophagy in a tightly regulated
manner [41]. In addition, autophagy-generated products
have been linked to innate and adaptive defenses [42,43].
Although OBs have been shown to express NLRP-3 re-
quired for caspase-1 activation associated with OB death
in response to infection [44], we find that MSU activates
NLRP3 in human OBs with no production of pro-IL-1β
or IL-1β. We identified a new role for NLRP3 in MSU-
induced autophagy in these bone cells. In OBs, MSU
upregulates NLRP3, which is a positive regulator of the
formation of MSU-autophagosomes. Phagocytosis of
MSU by OBs is a prerequisite process to MSU-induced
autophagy. However, signaling pathways of phagocytosis
by OBs are not similar to those of professional phago-
cytes. In addition, OBs stimulated by MSU reduce their
proliferation rate without change of their viability, and
MSU crystals remain intact inside OBs. Together with
the bone matrix irregularly calcified and the reduced
number of OBs present on the osteoid close to MSU
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crocrystals, when phagocytized by the nonprofessional
phagocyte OBs, activate NLRP3, which in turn upregu-
lates a nonproductive macroautophagy that fails to clear
MSU. Reduced anabolic functions and increased cata-
bolic functions of OBs subsequent to MSU phagocytosis
also suggest that MSU-activated OBs can be responsible
for reduction of calcified bone matrix and increase of
matrix degradation. Moreover, inefficient phagocytosis
and autophagy of these MSU microcrystals lead to




The incubation media α −MEM, FBS, and penicillin/
streptomycin were purchased from Wisent Inc. (St-Bruno,
QC, Canada). Triclinic MSU microcrystals were kindly
provided by Dr R. De Médicis (University of Sherbrooke,
Sherbrooke, QC, Canada) and were used under sterile
pyrogen-free conditions. The mean size of the MSU mi-
crocrystals used was 10 × 1.25 μm, as determined by
scanning electron microscopy. MSU was suspended at
10 mg/ml in α-MEM supplemented with 10% FBS. Accu-
tase was from eBioscience (San Diego, CA, USA). Calcein-
AM, propidium iodide (PI), cell-tracker orange CMTMR,
lipofectamine and Trizol were purchased from Invitrogen
Canada (Burlington, ON, Canada). Colchicine, cytochala-
sin D, SB203580, PD98069, 3-methyladenine, spautin-1,
dynasore, and alizarin red S (ARS) were obtained from
Sigma Chemical Co. (St. Louis, MO, USA). Piceatannol,
wortmannin, LY4294002, Gö6979, β-glycerophosphate,
and 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]-
pyrimidine (referred to as PP2) were from Calbiochem
(San Diego, CA, USA). GF109203X was from Biomol
International Lp (Plymouth Meeting, PA, USA). The
IκB antibodies were from Cell Signaling Technology
(Danvers, MA, USA). The rabbit polyclonal anti-pro-
IL-1β antibody was from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). IL-1β was assessed by using
the DuoSet ELISA Development kit (DY201; R&D
Systems, Minneapolis, MN, USA). The mouse monoclo-
nal anti-NLRP3 (NLRP3-a, or -b) antibody and the
rabbit polyclonal anti-LC3B antibody were from Novus
Biologicals (Littleton, CO, USA).
Cell preparation
All volunteers signed a consent form that included
participation to the present study and publication of the
results in accordance with the Declaration of Helsinki.
The institutional review board of the Université Laval ap-
proved the study. Primary OB cell cultures were prepared
from human trabecular bone explants obtained from fe-
male or male subjects (50 to 65 years old) undergoingorthopedic surgery for degenerative joint diseases. None
of the volunteers had metabolic bone disorders or malig-
nancy. Explants and subsequent conditions of culture
were as previously described [22,29,45,46]. In brief, OBs
were grown in α-MEM supplemented with 10% FBS. The
medium was replaced every 3 days until cellular conflu-
ence. At confluence, bone explants were transferred to
new six-well plates to allow remaining OBs to migrate and
adhere to the plate. Human OBs were recovered by using
the enzyme Accutase and plated at starting densities of
0.5 to 1 × 106 cells/well in α-MEM with 10% FBS. All in-
cubations were performed at the first cellular passage and
at 80% to 90% cellular confluence. OBs were all incubated
in medium with antibiotics (1% pen-strep) at 37°C in a hu-
midified atmosphere containing 5% CO2.
Evaluation of phagocytosis
Confluent OBs were stimulated 24 hours, 48 hours, or 3
or 7 days with MSU at 0.5 mg/106 cells and analyzed
with optic microscopy. To quantify phagocytic vacuoles
at 24 hours, five pictures randomly located in the well
were analyzed, and vacuoles containing MSU were num-
bered with a cell counter and Image J software (NIH).
Pharmacologic studies of MSU phagocytosis by OBs used
optimal concentrations of colchicine, cytochalasin D,
SB203580, PD98069, piceatannol, wortmannin, LY4294002,
Gö6979, GF109203X, and PP2, according to previous publi-
cations [47-55].
Viability
Confluent OBs were stimulated with 0.3, 0.5, or 1 mg
MSU/106 cells for 24, 48, or 72 hours. Cells were
washed with PBS and then detached by using Accutase
(500 μl/well) 10 minutes at 37°C. Necrotic and late apop-
totic cells were identified by PI incorporation (5 μg/ml)
and evaluated with cytofluorometry. Cells that did not in-
corporate PI have intact membranes and were considered
viable cells [56].
Proliferation assay
OB proliferation was evaluated by using the CellTiter 96
Aqueous One Solution Cell Proliferation Assay, as speci-
fied by the Promega manufacturer’s protocol (Madison,
WI, USA). In brief, 1,500 cells were plated in 96-well
plates on day 1 for 24 hours in 100 μl of α-MEM con-
taining 10% FBS, and then starved on day 2 with 100 μl
of α-MEM containing 0.1% FBS for 24 hours. On day 3,
cells were stimulated for 96 hours with vehicle or with
different concentrations of MSU in 100 μl of α-MEM
containing 10% FBS. After 96 hours, 20 μl of CellTiter
96 Aqueous One Solution Reagent (containing a tetrazo-
lium compound) were directly added to the culture
wells. Cells in the presence of the reagent were further
incubated for 3 hours at 37°C in a 5% CO2 humidified
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490 nm. The quantity of formazan product (from the
bioreduction of MTS tetrazolium compound by cells)
corresponding to the optical density at 490-nm absorb-
ance is directly proportional to the number of living cells
in culture.
Confocal microscopy
Confluent OBs were stained with 2 μM CMTMR (30 mi-
nutes, 37°C) and then stimulated with 0.5 mg of MSU
for 48 hours at 37°C. Confocal microscopy analyses were
performed with Olympus Fluoview 300 microscope by
using differential interference contrast (DIC) and helium-
neon (543 nm) lasers, magnification × 400.
Evaluation of mineralization
Mineralization of cell cultures was evaluated by alizarin
red S (ARS) staining. OBs were seeded at 2 × 105 cells/
well in six-well tissue-culture dishes and maintained in
α-MEM, 10% FBS supplemented with 10 mM β-
glycerophosphate, at 37°C in a humidified atmosphere
containing 5% CO2. Culture medium was replaced every
3 days until day 20. OBs were treated with MSU or ve-
hicle at day 8 (90% confluence). At day 20, cells were
fixed for 20 minutes with buffered formalin and then
stained for 20 minutes with 40 mM ARS, pH 4.0 to 4.2
at room temperature. After four washes with distilled
H2O, ARS was extracted, as previously described [57]. In
brief, ARS cells were incubated 30 minutes with acetic
acid and then heated 10 minutes at 85°C; pH was re-
stored at 4.2 with NaOH, and ARS absorbance was read
at 405 nm.
MMP activity
Evaluation of generic matrix metalloproteinases (MMP)
was assessed with the SensoLyte Generic MMP assay kit
(Anaspec, San Jose, CA, USA) that detects the activity of
a variety of MMPs, including MMP-1, 2, 3, 7, 8, 9, 12,
13, and 14. Five-FAM (fluorophore) and QXL520
(quencher), labeled FRET peptide substrates, were used
for continuous measurement of the enzyme activities.
On the cleavage of the FRET peptide by MMPs, the
fluorescence of 5-FAM was recovered and monitored at
excitation/emission wavelengths of 490 nm/520 nm.
Confluent OBs were treated 24 hours with or without
0.5 mg MSU in α-MEM containing 1% FBS. Medium
was then centrifuged 2 minutes at 10,000 rpm, and 50 μl
of supernatant was added to 50 μl of MMP substrate for
20 minutes. MMP activity in MSU-stimulated cells was
compared with MMP activity in untreated cells.
RNA isolation and real-time PCR
OB total RNA was isolated by using Trizol (Invitrogen
Lifetechnology). In brief, around 106 confluent cells,stimulated with MSU or vehicle, were washed in PBS
and then homogenized in 1 ml Trizol. Total RNA was
then extracted, according to the manufacturer’s protocol.
Reverse-transcription and real-time PCR were performed
essentially as previously described in [58]. In brief, first-
strand cDNA synthesis was performed by using 1 μg of
total RNA with Superscript II (Invitrogen Lifetechnology)
in recommended conditions, with 10 ng of random hex-
amers. Amplification of osteoblast cDNA was carried out
in a Rotor-Gene 3000 operated with Rotor Gene software
version 6.0.19 (Corbett Reasearch, Mortlake, 2137 NWS,
Australia). Each sample consisted of: 50 ng cDNA,
1.3 mM MgCl2, 0.2 mM dNTP, 500 nM primers, 0.5 unit
of Taq polymerase (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden), and Sybr Green dye (Molecular Probes,
Eugene, OR, USA; 1/30,000 dilution) in a reaction volume
of 20 μl.
Amplification conditions were as follows: 95°C
(20 seconds), 60°C (20 seconds), 72°C (20 seconds);
35 cycles. Specificity of each reaction was ascertained
by performing the Melt procedure (58°C to 99°C; 1°C/
5 seconds) after completion of the amplification protocol,
according to the manufacturer’s instructions. Primers used
in real-time PCR procedures were designed with Primer 3
software as GAPDH: 5′-CGAGATCCCTCC-AAAATC





Signaling pathways were investigated by using the Proteome
Profiler arrays (R&D Systems, Minneapolis, MN, USA).
The Human Phospho-Kinase array is a nitrocellulose
membrane where antibodies against 46 kinase phosphor-
ylation sites have been spotted in duplicate. Cell lysates
from untreated, 5 minute, 20 minute, and 1 hour MSU-
activated cells were prepared in lysis buffer provided with
the proteome profiler (R&D). In total, 250 μg of protein
was used for each array and incubated with the nitrocellu-
lose membrane array overnight at 4°C. The array was
washed and then incubated with a cocktail of phospho-
site-specific biotinylated antibodies for 2 hours at room
temperature, and washed before adding Streptavidin–HRP
for 30 minutes. Signals were developed with an enhanced
chemiluminescence Western blotting detection system
and recorded on x-ray film. Densities of individual dots
corresponding to a phosphorylated kinase were measured
by Image J software, and a comparison between untreated
and MSU-activated samples was performed.
Immunoblot analysis
After incubation, around 5.105 confluent adhering OBs
were washed with PBS and then directly lysed in Laemmli
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subjected to 15% SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to Immobilon membranes
(Millipore Corporation, Billerica, MA, USA). Equal pro-
tein loading and transfer efficiency were visualized with
β-actin evaluation. Membranes were saturated for 30 mi-
nutes at room temperature in Tris-buffered saline (TBS,
25 mM Tris–HCl, pH 7.6, 0.2M NaCl) with 0.5% Tween
20, containing 5% (wt/vol) dried milk, and subsequently
exposed overnight at 4°C to the LC3-B rabbit polyclonal
antibody, NLRP-3b mouse monoclonal antibody, P-IκB or
IκB mouse antibodies, or 1 hour at room temperature to
the actin mouse monoclonal antibody. Membranes were
washed twice in TBS-Tween and incubated with second-
ary antibodies. Bounded antibodies were revealed with the
enhanced chemiluminescence Western blotting detection
system after TBS-Tween washes, as specified by the man-
ufacturer’s protocol (Pierce Biotechnology, Thermo Fisher
Scientific, Rockford, IL, USA).
LC3-GFP transfection
OBs (90% confluence) were transfected with LC3-GFP
plasmid (gift from Dr T. Yoshimori, Osaka University,
Japan) for 24 hours by using lipofectamine, according to
the manufacturer’s protocol. After 4 hours of MSU
stimulation, cells were then observed with confocal mi-
croscopy (Olympus Fluoview 300 microscope using a
helium-neon (488 nm) laser, ×400 magnification).
Small interfering RNA knockdown of NLRP3 expression
Knockdown of NLRP3 expression was achieved by trans-
fecting OBs with a combination of two small interfering
RNAs (siRNAs) against NLRP3 or AllStars Negative
Control siRNA (Qiagen Inc., Mississauga, ON, Canada).
Predesigned siRNAs against NLRP3 target sequences
were SI02634009 and SI02634030. OBs were transfected
with these siRNAs in the presence of HiPerFect Trans-
fection Reagent by following the manufacturer’s protocol
(Qiagen). After 24 hours of transfection, knockdown of
NLRP3 protein expression was confirmed with immuno-
blot, and these cells were stimulated or not with 0.5 mg
MSU for 8 hours.
Densitometric analyses
Immunoblots were analyzed by using ImageJ software
(Image Processing and Analysis in Java, NIH) to quantify
band intensity assessed with densitometry. Results are pre-
sented as mean values of arbitrary densitometric units
normalized to the expression of β-actin or as levels in
MSU-stimulated cells over levels in unstimulated cells.
Statistics
Results are expressed as mean ± SEM. Statistical analyses
were performed by using GraphPad Instat 3.0 (GraphPadSoftware Inc., San Diego, CA, USA). Two groups were
analyzed by using paired or unpaired t tests. For
three groups and more, statistical analyses were per-
formed by using the one-way ANOVA Bonferroni multiple-
comparison test or the repeated measures ANOVA,
followed by Tukey multiple-comparison test. Signifi-
cance was set at P < 0.05.
Results
Human osteoblasts internalize MSU
OBs are known to ingest MSU microcrystals in vitro
with some efficacy [22]. These observations, together
with the pathologic findings of MSU included in bone
matrix and a scarce presence of OB close to tophaceous
bone lesions [29], suggest that OBs are unable to destroy
these crystals. Thus, MSU could remain intact inside
OBs and deregulate specialized functions of OBs.
To evaluate the fate of MSU in the presence of OBs,
live confluent primary human OBs were cultured with
graded concentrations of MSU during 7 days. OBs that
phagocytized MSU showed, after 48 hours of incubation,
consistent morphologic changes, as studied with con-
focal microscopy. OBs dose-dependently internalized
MSU from 0.1 to 1 mg/106 cells with an optimal effect
at 0.5 mg/106 cells, followed by a plateau (data not
shown). More than 90% of OBs had MSU internalized in
large and fluid-filled vacuoles, each containing a single
microcrystal (Figure 1). Volume and shape of vacuoles
depend on crystal size. Vacuoles were individualized
with light microscopy after, at least, 24 hours of incuba-
tion. Numbers of vacuoles with MSU averaged 30 per
OB. Most of MSU were completely internalized in cells,
but some crystals remained partially engulfed or along-
side the membrane. After 7 days of culture, phagocytosis
of 0.5 mg MSU/106 OBs was associated with unchanged
vacuoles (data not shown). These data suggest a pro-
longed process that could partly detoxify the cells by
retaining MSU microcrystals in permanent phagosomes
with a final noncapacity of OB to eliminate MSU-
containing vacuoles.
MSU affects OB proliferation but not viability
Because MSU can modulate cellular apoptosis and
proliferation [59,60], the impact of MSU on OB sur-
vival and proliferation was evaluated before studying
specialized OB functions. MSU at concentrations up
to 1 mg/106 cells for 72 hours of culture did not
modify the incorporation of propidium iodide (PI) by
OBs, and an average of 80% PI-negative OBs was rou-
tinely obtained in control conditions, as well as in the
presence of MSU (Figure 2A). In contrast, the prolif-
eration rate of MSU-treated OBs dose-dependently
decreased from 0.1 to 1 mg MSU/106 cells (Figure 2B).
The significant threshold reduction was observed at
Figure 1 Phagocytosis of monosodium urate by osteoblasts. Confluent human OBs, previously stained with CellTracker Orange CMTMR, were
cultured with vehicle (A) or with 0.5 mg MSU/106 cells (B) for 48 hours at 37°C, and then analyzed with confocal microscopy by using Olympus
Fluoview microscope with helium-neon 543-nm lasers (left panel), differential interference contrast (DIC; middle panel), and overlap (right panel);
×400 magnification. Arrows indicate vacuoles and crystals of MSU. Representative of independent experiments with OB from three
different donors.
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0.8 mg MSU. The respective proliferation rates were re-
duced from 30% to 55% of the OB proliferation rate in
control conditions. Thus, although MSU microcrystals at
the concentrations tested did not modify the viability of
OBs, they significantly decreased the proliferation of OBs
and could, in parallel, affect other functions.
MSU alters OB functions
Mineralization
MSU present in the culture medium of human OBs
affects parameters implicated in bone mineralization,
such as alkaline phosphatase activity and osteocalcin
content [22]. To assess the mineralization function of
OBs in the presence of MSU or vehicle in vitro, OB
cultures were stained with alizarin red S (ARS), a marker
of matrix calcium that allows a quantitative evaluation
of mineralization [57,61]. OBs incubated with MSU
showed a reduced ARS staining of the newly calcified
matrix (Figure 3A). The quantities of ARS in cultures
of MSU-activated OBs were dose-dependently de-
creased by 1.6- and 2.1-fold compared with those ob-
served in vehicle-treated OBs (Figure 3B). Moreover,
the addition of MSU suppressed in a time-dependent
manner the expression of the mRNA of procollagen-α1, a
typical bone-matrix constituent, with a sixfold decrease
at 48 hours in the presence of 1 mg MSU (Figure 3C).These data indicate that MSU affects the formation of
certain matrix components and in fine bone matrix
mineralization.
MMP activity
Bone matrix degradation depends, among other factors,
on enzymes such as matrix metalloproteinases (MMPs)
that are known to be implicated in pathophysiological
processes [62]. Although bone-matrix degradation is re-
lated mainly to osteoclasts, OBs can also be involved in
bone resorption through their production of several
MMPs [63-65]. The activity of generic MMPs, as
evaluated in supernatants of OBs cultured with MSU,
was increased by 120% over that of unstimulated cells
(Figure 3D). These results indicate that MSU-stimulated
OBs may be directly implicated in matrix degradation of
bone with MSU deposits.
Phagocytosis of MSU by OBs is tightly regulated
Signaling pathways affected by MSU
These data document profound effects of MSU on the
behavior of OBs. These data indicate that the pathways
regulating OB functions are likely to be affected by the
presence of MSU. By using a protein kinase array that
detects specific phosphorylation of 46 kinase phos-
phorylation sites, certain effector signaling proteins
were investigated in MSU-stimulated OBs (Figure 4A).
Figure 2 Effects of MSU on OB viability and proliferation. (A)
Confluent OBs were incubated with vehicle (control) or with MSU
from 0.3 to 1 mg/106 cells for 24, 48, or 72 hours. Cells were washed
with PBS and removed with Accutase. Propidium iodide (PI)
exclusion was analyzed with cytofluorometry. (B) Cells were plated
3 days with vehicle or with MSU in 96 wells and then analyzed with
the CellTiter 96 AQueous One proliferation assay. Data are represented
as a ratio of MSU-stimulated to vehicle-stimulated cells. Results
are given as mean ± SEM of values from four (A) or three
(B) different donors. Statistical analysis: one-way ANOVA followed
by Bonferroni multiple-comparison test: ns, nonsignificant; means
without a common letter differ: P < 0.05.
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were higher than those recorded at 5 and 20 minutes (data
not shown). Thus, a 1-hour MSU stimulation of OBs was
associated with a phosphorylation increase of p38α (T180/
Y182) by 86% and ERK 1/2 (T202/Y204, T185/Y187)
by 94% (Figure 4B), whereas the phosphorylation of
Src kinases tended to be inhibited (Src (Y419), Yes (Y426),
Hck (Y411), Fyn(Y420)) or unchanged (Fgr (Y412), Lck
(Y394)) (Figure 4C). Additionally, phosphorylation of the
serine/threonine protein kinases TOR and p70S6K was
decreased by the presence of MSU (Figure 4D).
Pharmacologic modulation of phagocytosis
Considering these results on signaling pathways suggest-
ing that MSU modulated the phosphorylation status of
various kinases, the investigation was pursued to deter-
mine the role in OBs of those kinases that are known to
be implicated in phagocytosis, a dynamic mechanism of
endocytizing particles. The engulfment of large particles
is governed by the microfilament and microtubulecytoskeletons. Therefore, the effects of cytochalasin D,
an inhibitor of actin polymerization, and colchicine, an
inhibitor of microtubule polymerization, were examined
on MSU internalization by OBs (Table 1). Cytochalasin
D pretreatment abrogated the formation of vacuoles as-
sociated with MSU phagocytosis. In contrast, colchicine
did not inhibit the appearance of vacuoles containing
MSU. Mechanisms underlying phagocytosis also impli-
cate several intracellular signaling pathways that lead to
cytoskeleton reorganization and ingestion of particles.
From that point of view, pharmacological inhibitors can
help decipher signaling pathways associated with MSU
phagocytosis by OBs (Table 1). The phosphoinositide 3-
kinases that control cytoskeleton dynamics, signal trans-
duction, and membrane trafficking [66,67] were targeted
by two pan-PI3K inhibitors, wortmannin and LY294002.
Both inhibitors reduced by 50% the vacuole-formation
process, suggesting a role of PI3K in the internalization
of MSU by OBs. Protein kinase C (PKC) can also be in-
volved in the transduction of phagocytic signals [68].
The inhibitor of pan-PKC isoforms GF109203X (GFX)
and the inhibitor of classic-type PKC isoforms Gö6976
were found to reduce by approximately 60% and 70%
MSU-vacuole formation, respectively, thereby support-
ing an involvement of PKC in this process. The extracel-
lular kinase (ERK1/2) inhibitor PD98069 reduced by
44% the MSU-induced formation of vacuoles, confirm-
ing an implication of these MAPK in the process of
vacuole formation by OBs. As Syk tyrosine kinases have
been shown to control phagocytosis [25,69], the Syk in-
hibitor piceatannol was tested on MSU-activated OBs.
Piceatannol reduced the MSU-induced formation of vac-
uoles by 58%, indicating an involvement of Syk kinases
in this process. Surprisingly, the inhibition of Src kinases
by PP2 failed to modulate the MSU-induced formation
of vacuoles, whereas PP2 completely inhibited Src ki-
nases in MSU-activated neutrophils (data not shown).
Conversely, OB preincubated with the p38 MAPK in-
hibitor SB203580 exhibited a twofold increase of MSU-
induced vacuole formation. Together, these results
indicate that phagocytosis and vacuole formation by OBs
in the presence of MSU are dependent, at least in part,
on different types of kinases like PI3K, PKC, ERK1/2,
and p38 MAPK, and Syk and are independent of Src ki-
nases. Moreover, ERK1/2 and p38 MAPK show antagon-
istic effects on this process in OBs.
MSU activates autophagy in OBs
Proteome-profiler analyses revealed that the phosphoryl-
ation of TOR (S2448), as well as of the marker of TOR
activity p70S6K (T389, T421/424, T229), was decreased
after MSU stimulation (Figure 4D). TOR is a repressor
of autophagy, and diminution in TOR phosphorylation
allows autophagy [70]. Because uric acid has been found
Figure 3 OB functions of matrix mineralization, procollagen-α1 expression, and matrix metalloproteinase (MMP) activity. (A, B)
Mineralization in vitro by normal human OBs. Cells were cultured 20 days in the presence of 10 mM β-glycerophosphate and stimulated with
vehicle (control) or with 0.5 and 1 mg MSU for 12 days before alizarin red staining (ARS). (A) Representative ARS staining in vehicle- or
MSU-stimulated OBs. (B) Quantification of ARS, values are shown as mean ± SEM from three different donors. (C) Expression of procollagen-α1 by
OBs stimulated with MSU. Cells were incubated with vehicle or with 1 mg MSU for 12, 24, and 48 hours. Gene expression was evaluated with
QRT-PCR. Results were GAPDH-normalized and expressed as procollagen-α1 expression by MSU-stimulated OBs relative to unstimulated cells
(fold increase). (D) Evaluation of generic MMP activity. Confluent OBs were incubated with vehicle (Control) or with 0.5 mg MSU for 24 hours,
and MMP activity in the supernatant was evaluated according to the manufacturer’s protocol. MMP activity in MSU-stimulated cells was calculated
as the ratio of MSU-stimulated cells to vehicle-treated cells (control referred to as 100%). Statistics: (B) and (C) were analyzed by using one-way
ANOVA followed by Tukey multiple-comparison test (n = 4 different donors); means without a common letter differ: P < 0.05. (D) Absorbance
values were compared by using paired two-tailed t tests. **P = 0.002 (n = 5 different donors).
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could alert OBs through an autophagic response
based on these data showing that the TOR pathway
was downregulated and that MSU-activated OBs re-
duced their proliferation without alteration of their
viability. Microtubule-associated protein LC3 is an ef-
fector of macroautophagy, and its cleavage and lipida-
tion have been used as a specific marker to monitor
autophagy [71]. MSU dose- and time-dependently in-
duced the cleavage of LC3-I into LC3-II (Figure 5A, B).
In addition, preincubation of OBs with 3-methyladenine,
an inhibitor of autophagic sequestration through class
III PI3K [39], or with wortmannin, an inhibitor of PI3K
involved in autophagy and phagocytosis [72,73], abolished
the cleavage of LC3-I into LC3-II (Figure 5C). Experiments
were also performed with OBs preincubated with spautin-
1, an inhibitor of autophagy that targets the beclin1
subunit of Vps34 complexes [74]. Spautin-1 efficientlyinhibited the cleavage of LC3-I into LC3-II in MSU-
activated OBs (P < 0.05; n = 3). Moreover, the addition of
MSU to OBs transfected with green fluorescent protein
(GFP)-tagged LC3 showed a rapid increase of labeled vac-
uoles in their cytosol, as well as MSU coated with GFP-
tagged LC3 (Figure 5D). These results indicate that MSU
in human OBs induced endogenous LC3 conversion and
stimulated the process of autophagy while they were pro-
gressively engulfed in OBs.
After our pharmacologic study (see earlier) that indi-
cated activation of signaling pathways involved in both
autophagy and phagocytosis, and because giant vacuoles
containing MSU appeared comparatively late versus the
rapid generation of autophagosomes, was the primum
movens to destroy these solid particles autophagy or
phagocytosis? Dynasore, a dynamin inhibitor, was used
to abrogate the phagocytic pathways by blocking vesicle
formation [75,76]. Interestingly, pretreatment of OBs
Figure 4 Phosphoproteomic analysis of MSU-stimulated OBs. The Human Phospho-Kinase Array was used to detect multiple phosphorylated
kinases in OBs, either untreated or stimulated with 1 mg MSU for 60 minutes. (A) Template showing the location of kinase antibodies spotted
onto the Human Phospho-Kinase Array kit. Positive and negative controls are indicated by + and – adjacent to appropriate spots. Signals of
relevant kinases in response to MSU stimulation are indicated by numbers. (B, C, D) Quantification of mean spot pixel densities of untreated cells
(white) versus MSU-stimulated cells (black). (B) Representation of phosphorylated MAP kinases. (C) Phosphorylated Src kinase family. (D) Phosphorylated
TOR and p70S6K. Representative of independent experiments with OB from three different donors. Results are shown as mean ± SEM of
densitometric values (n = 3). Statistical analysis was performed by using the paired two-tailed t test to compare phosphorylated proteins from
OBs under MSU versus vehicle; *P < 0.05.
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cleavage of LC3-I into LC3-II (Figure 5E), suggesting
that phagocytosis precedes autophagy and that MSU-
activated autophagy directly depends on crystal phagocyt-
osis by OBs.
MSU stimulates NLRP3 in OBs
MSU microcrystals ingested by macrophages have been
shown to stimulate the production of IL-1β through the
NLRP3 inflammasome [9]. Because NLRP3 is expressed
by OBs [44], we examined next whether MSU in OBs is
capable of activating the NLRP3 inflammasome. As a
first step, we investigated whether IL-1β was produced
by OBs in the presence of 0.5 mg MSU/106 cells for 24
and 48 hours of culture. No extracellular IL-1β (as eval-
uated with EIA) or intracellular pro-IL-1β (as evaluated
with immunoblot), even in the presence of 1 mM ATP,
which activates NLRP-3 [77], was detected in MSU-
stimulated OBs (data not shown). However, OBs ex-
posed to MSU increased their expression of NLRP3
protein, which peaked at 12 hours of MSU stimulationand decreased after 24 hours, as evaluated with densitom-
etry (Figure 6A, B).
Conversely, NF-κB is activated by solid particles
ingested by OBs and by MSU in monocytic cells [20,28].
Its activation was assessed through the kinetic phosphor-
ylation of its inhibitor IκB in OBs in the presence of
MSU. No modification of IκB phosphorylation was
detected in OBs activated by MSU, whereas TNF-α
addition to OBs was typically associated with changes of
IκB phosphorylation (Figure 6C). Overall, these results
indicate that OBs respond to MSU (a) by a primary non-
conventional phagocytosis followed by (b) a secondary
autophagy, (c) by activating NLRP3 protein without con-
comitant IL-1β generation, and (d) by no signal through
the NF-κB pathway.
MSU-stimulated autophagy is regulated by NLRP3
Under certain conditions like bacterial infection of
macrophages, another inflammasome, the NLRC4/Ipaf
inflammasome, has been reported to downregulate
autophagy independent of IL-1β production [78]. In
Table 1 Effect of pharmacologic inhibitors on MSU
phagocytosis by OBs
Vacuole number (statistics)*
Control 13.1 ± 3.7 (a)
+ MSU 361 ± 27 (b)
Cytochalasin D +MSU 23.2 ± 10.7 (a)
Colchicine + MSU 321 ± 60 (b)
Control 14.5 ± 3.0 (a)
+ MSU 323 ± 32 (b)
Wortmannin + MSU 157 ± 31 (c)
LY4294002 + MSU 146 ± 27 (c)
Control 16.1 ± 3.2 (a)
+ MSU 281 ± 52 (b)
GF109203X +MSU 126 ± 10 (a)
Gö6976 + MSU 95 ± 10 (a)
SB203580 + MSU 612 ± 101 (c)
PD98069 +MSU 157 ± 39 (a)
Control 16.3 ± 3.2 (a)
+ MSU 193 ± 23 (b)
Piceatannol + MSU 82 ± 20 (a)
PP2 +MSU 231 ± 42 (b)
Confluent OBs were preincubated 15 minutes with 1 μM cytochalasin D or
10 μM colchicine at 37°C and then stimulated with 0.5 mg MSU/106 cells for
24 hours. Confluent OBs were preincubated with PI3K inhibitors: wortmannin
50 nM or LY4294002 10 μM, with PKC inhibitors: GF109203X 5 μM or Gö6976
1 μM, with p38 or ERK1/2 inhibitors: SB203580 10 μM or PD98069 20 μM, or
with a Syk inhibitor: piceatannol 20 μM and a Src inhibitor: PP2 10 μM,
15 minutes at 37°C and then stimulated with 0.5 mg MSU/106 cells for
24 hours. Cells were analyzed with microscopy (×200 magnification), and
results expressed as cumulative data means of values ± SEM of five pictures
for each donor. Statistical analysis was performed on vacuole counts by using
the repeated measures ANOVA followed by Tukey multiple-comparison test
(n = 4 different donors). *Means without a common letter differ: P < 0.05.
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NOD1 and NOD2, are intracellular sensors that in-
duce autophagy independent of NF-κB [79,80]. Could
NLRP3 be implicated in the regulation of autophagy
activated by MSU in OBs? To determine the role of
NLRP3 in MSU-mediated autophagy, siRNAs were used
to knockdown the expression of NLRP3 in OBs. Transfec-
tion of OBs with a combination of two NLRP3-specific
siRNAs inhibited by 44% ± 9% the NLRP3 expression acti-
vated by MSU (Figure 7A). In addition, the LC3-II cleav-
age induced by MSU was decreased by 23% ± 1% in
NLRP3 knockdown OBs (Figure 7B). These results indi-
cate that NLRP3 activated by MSU in OBs is implicated in
the upregulation of autophagy.
Discussion
NLRP3 belongs to the family of cytosolic NLR proteins
that help respond to a danger by recognition of bacterial
particles, chemicals, and products from injured cells.Once activated, NLRP3 proteins associate with other
cytosolic proteins to form an inflammasome presently
known as a pivotal structure in the inflammatory process
and in diseases in which IL-1β is greatly involved. NLRP3
activation is a hallmark of professional phagocytes involved
in the immune responses. However, nonprofessional
phagocytes also express NLRP3. Interestingly, two mem-
bers of the NLR protein family, the intracellular sensors
nucleotide-binding oligomerization domain-containing
protein-1 and −2, are already coupled to autophagy [80].
Here, we identify a new role for another NLR protein,
NLRP3, as a positive regulator of autophagy in response
to the danger-signal MSU in human OBs. The functional
relevance of this mechanism was shown by knockdown
of NLRP3 and by blocking the process of MSU phago-
cytosis, which both led to the absence of cleavage of
LC3-II. Thus, MSU provoked in OBs two different pat-
terns of activation that appear closely related, an initial
and necessary event of phagocytosis followed by a rapid
induction of autophagy with the appearance of autopha-
gosomes, conditions that together should lead to the
complete removal of MSU. One of the major functions
of autophagy through tightly controlled formation of
autophagosomes is devoted to the removal of particles
that escape degradation in conventional phagosomes
[81,82]. However, the present results indicate that both
primary processes of phagocytosis and autophagy in OBs
are not followed by the degradation of internalized MSU
microcrystals that remain intact inside persistent autop-
hagosomes. In addition, survival of OBs is not affected
by MSU, but their proliferation is reduced.
Our present results of the absence of MSU effect on
OB mortality seems apparently in contradiction to a pre-
vious study that reported an inhibition of OB viability by
MSU [83]. However, major experimental differences be-
tween this report and the present study can explain this
discrepancy. The experiments presented here were
performed with primary human OBs only, whereas
Chhana’s studies [83] were carried out mostly with
murine MC3T3-E1 cells, and the only viability data
with human primary OBs of the published report
used the MTT assay, which is, at best, an assay evalu-
ating cell proliferation and that requires controlling
several important parameters, to be an indirect test of
cell viability [84]. Moreover, in the present study, we
evaluate only PI incorporation by OBs, which repre-
sents a useful quantification of necrotic and late
apoptotic cells [56]. Interestingly, although OB prolif-
eration is reduced by MSU, their catabolic functions
are activated because they are always alive after 7 days
of culture. The absence of degradation of MSU by
these nonprofessional phagocytes was corroborated
with the findings of MSU directly encrusted in the ir-
regular matrix of gouty lesions of bone [29].
Figure 5 MSU induces endogenous LC3 conversion. (A) Expression levels of LC3-I and LC3-II after MSU stimulation. Confluent OBs were
cultured in α-MEM with 10% FBS and were stimulated with 0.1 to 1 mg MSU for 24 hours. Reactions were stopped, and cells were prepared to
perform immunoblot analysis with anti-LC3-I/LC3-II and anti-β-actin antibodies. (B) Kinetic effects of MSU. OBs were cultured as in (A) and
stimulated by 0.5 mg MSU for the indicated times. (C) Effects of 3-methyladenine (3-MA), wortmannin (W), and spautin-1 on MSU-induced
conversion of LC3. Cells were pretreated with vehicle (CONT), 3-MA 6 μM, W 50 nM, or spautin-1 (10 μM) for 30 minutes. The cells were then
stimulated with 0.5 mg MSU for 24 hours in the absence or in the continuous presence of 3-MA, W, or spautin-1. Immunoblots are representative
of four different donors (3-MA, W), and of three different donors (spautin-1). (D) Autophagosome localization in GFP-LC3-transfected OBs.
OBs were transfected with GFP-LC3 plasmid and then incubated with vehicle (Control) or 0.5 mg MSU for 4 hours before analysis with confocal
microscopy (×200 magnification). (E) Effects of Dynasore on MSU-induced conversion of LC3. Confluent OBs were pretreated with vehicle (CONT)
or 80 μM Dynasore for 10 minutes, and then incubated with vehicle or 0.5 mg MSU for 24 hours. Data are expressed as arbitrary densitometric
units normalized by β-actin levels; LC3-II conversion induced by MSU was the ratio of LC3-II levels of MSU-stimulated cells over LC3-II levels of
vehicle-stimulated cells. The effect of Dynasore is presented as mean value ± SEM of percentage inhibition of LC3-II conversion. Statistical analysis
was performed by using the paired two-tailed t test (n = 3 different donors); *P < 0.05.
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layed for up to 24 hours, and NLRP3, which precedes
the cleavage of LC3-I into LC3-II, appeared within
3 hours in MSU-stimulated OB, intracellular signaling
indicated a rapid activation of both autophagy and
phagocytosis. Moreover, the process of phagocytosis ap-
peared an absolute necessity for subsequent autophagy
of MSU, as shown by the absence of MSU autophagysecondarily to phagocytosis blockade. These sequences
of phagocytosis followed by autophagy seem logical, be-
cause autophagy is aimed at destroying intracellular par-
ticles, whereas phagocytosis, also aimed at degrading
foreign particles, is the process that will internalize
extracellular particles. However, phagocytosis could have
been sufficient to destroy MSU. Interestingly, MSU in
the presence of OBs, nonprofessional phagocytes, can
Figure 6 MSU activates NLRP-3 without any effect on the NF-κB pathway. (A) Expression levels of NLRP-3 during MSU stimulation. Confluent
cells were stimulated with 0.5 mg MSU for the indicated times and then subjected to immunoblot analysis by using anti-NLRP-3 and anti-β-actin
antibodies. Macrophages (MΦ) stimulated for 24 hours with LPS, 100 ng/ml, were used as positive control. (B) Quantification of NLRP-3 levels in
MSU-stimulated OBs. Pixel-density results were normalized with β-actin, and cumulative data are expressed as mean ± SEM (three different donors).
Statistical analysis was performed by using the one-way ANOVA Bonferroni multiple-comparison test; means without a common letter differ: P < 0.05.
(C) Analysis of the NF-κB pathway activation. Confluent OBs were stimulated with 0.5 mg MSU for the indicated times. Protein lysates were subjected
to immunoblot analysis for phosphorylated IκB (P-IκB) or IκB. As a positive control for IκB phosphorylation, OBs were stimulated with TNF-α (50 ng/ml)
for the indicated times.
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through the rapid induction of NLRP3 to complete the
degradation of MSU. It has been reported that autoph-
agy participates in degrading extracellular microorgan-
isms linking autophagy to phagocytosis [30,85]. It is also
important to stress that NLRP3 activated by MSU in
OBs does not engage the inflammasome signaling path-
ways, as it does in professional phagocytes [77], because
expression of the adaptor ASC was not increased, and no
activation of caspase-1 was detected in MSU-stimulated
OBs (data not shown). Our results demonstrate that
NLRP3 has an inflammasome-independent, cell-intrinsic
effect in OBs ingesting MSU microcrystals.
MSU interaction with OBs also seems particularly ori-
ginal at the level of kinetics and regulation of phagocyt-
osis. First, engulfment of MSU by OBs is related to a
process of phagocytosis, because cytochalasin D blocked
entirely MSU internalization, whereas colchicine, an in-
hibitor of microtubule polymerization, had no effect.
OBs can ingest various foreign particles like MSU, titan-
ium (Ti), latex beads, or microorganisms like Escherichia
coli or Candida albicans [19,86]. However, Ti, for in-
stance, activates NF-κB in OBs [20], whereas MSU did
not. Moreover, this difference of signals involved in
MSU phagocytosis is also demonstrated at the level ofSrc kinases required for phagocytosis by professional
phagocytes [87], whereas they are not required by OBs.
In addition, ERK1/2 and p38 MAPK, which positively
regulate conventional phagocytosis, have opposite ef-
fects in MSU-activated OBs as human phosphokinase
array revealed a phosphorylation of p38 MAPK, but
SB203580, an inhibitor of p38, did not reduce but fa-
cilitated phagocytosis. Our results suggest that phago-
cytic stimulation by MSU required ERK activation but
not p38, which seems to act as a repressor of MSU phago-
cytosis by OBs. Such antagonistic roles of ERK1/2 and
p38 MAPK are reminiscent of another condition in which
ERK1/2 and p38 MAPK differentially regulate heme bio-
synthesis [88].
The primary function of both phagocytosis and au-
tophagy is to maintain cellular homeostasis by degrading
foreign particles that can represent successively an extra-
cellular danger and, after their ingestion, another intra-
cellular danger, if phagocytosis failed in its function of
destruction. Interestingly, even if extracellular MSU
crystals present a major proinflammatory potential, they
have been recognized as an endogenous danger signal
useful to immunity [6]. From the presence of such MSU
crystals in cells and tissues emerges the concept of their
degradation. It is well known that an attack of gout can
Figure 7 NLRP3 upregulates MSU-induced autophagy. OBs were transfected with AllStars Negative Control siRNA or NLRP3-specific siRNAs for
24 hours and then left unstimulated or stimulated with 0.5 mg MSU for 8 hours. (A) Immunoblot analysis using anti-NLRP3 and anti-β-actin
antibodies. Densitometric analyses of NLRP3 expression. Data are expressed as arbitrary densitometric units normalized by β-actin levels; NLRP3
was presented as the ratio of NLRP3 levels of MSU-stimulated cells to NLRP3 levels of vehicle-stimulated cells. Statistical analysis was performed
by using the paired two-tailed t test (n = 4 different donors). (B) Immunoblot analysis using anti-LC3 and anti-β-actin antibodies. Data are
expressed as arbitrary densitometric units normalized by β-actin levels; LC3-II conversion induced by MSU was the ratio of LC3-II levels of
MSU-stimulated cells to LC3-II levels of vehicle-stimulated cells. Results are expressed as mean ± SEM (n = 4 different donors). Statistical analysis
was performed by using the paired two-tailed t test; *P < 0.05; **P < 0.001.
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in joints and tissues. MSU deposits can be shown in vari-
ous tissues from the joint to cartilage, bone, vasculature,
skin, and kidney. It seems that once crystallized in
humans, MSU cannot be easily and spontaneously de-
graded. Our results seem to confirm that notion, at least
in bone tissues.
The difference between professional and nonprofes-
sional phagocytes relies on, at least in part, their rap-
idity and efficiency of phagocytosis [89]. Although
neutrophils rapidly ingest MSU in vitro, only a few
neutrophils are shown with intracellular microcrystals,
and these neutrophils rapidly die with release of cel-
lular content [90,91]. Macrophages poorly ingest MSU
microcrystals that have, however, profound stimula-
tory effects on these phagocytes [92,93]. In contrast,
most of the OBs that slowly vacuolize microcrystals,ingested MSU but did not die from this process.
Moreover, OBs in contact with MSU crystals rapidly
stimulate signaling of phagocytosis and NLRP3 for
their subsequent autophagy, both mechanisms of particle
destruction that fail in MSU degradation. OBs with
MSU crystals inside did not die, but showed pro-
found changes of their functions, becoming bone
cells that have reduced capacity of mineralization,
that degrade the calcified matrix, but that have no
change of RANKL and OPG mRNAs (RT-PCR data
not shown). Also, the upregulation of autophagy by
NLRP3 in these conditions did not generate IL-1β,
although mammalian cells can produce IL-1β via an
autophagy-based secretory pathway [94]. However,
the absence of IL-1β production by OBs could also
be related to their incapacity to translate mRNA, as
reported for OB phagocytosis of Staphylococcus aureus
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activated by MSU in OBs could partly detoxify these
cells by retaining MSU microcrystals in permanent
autophagosomes.
Conclusion
MSU crystals in the presence of the nonprofessional
phagocytes OB selectively activate the MAPK pathways,
without any effect on NF-κB and Src kinases, leading
successively to the two primary processes of degradation
of foreign particles that penetrate inside the cell, phago-
cytosis and autophagy. However, despite a rapid upregu-
lation of autophagy through NLRP3, MSU microcrystals
remain intact inside OBs that do not affect their survival
but reduce their proliferation. The present osteoblastic
consequences of MSU ingestion are profound modifica-
tions of their functional phenotype that, in the context
of bone tissues in gout, validate the pathologic findings
of MSU microcrystals remaining encrusted in bone.
Hence, NLRP3 could upregulate autophagy in other
pathologic conditions and could have an important func-
tion in diseases.
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